Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Chronic headaches are a major cause of disability among adolescents. Cannabis products have
supported the management of headaches in adults and may play a role in pediatric chronic
pain. We propose a multisite, open-label, tolerability study conducted across three centers
in Canada of Cannabidiol-enriched Cannabis Herbal Extract in adolescents (ages 14 to 17 years
old) with chronic headaches. The study includes a one month baseline assessment, four months
of escalating treatment doses and a weaning period. Our primary outcome is tolerability
defined as the number and severity of reported adverse events.
Phase:
Phase 1
Details
Lead Sponsor:
University of Manitoba
Collaborators:
SickKids Foundation The Canadian Collaborative for Childhood Cannabinoid Therapeutics